Pasar al contenido principal

ANALISIS CUANTITATIVO DE ORGANOIDES DERIVADOS DE PACIENTES DE ALTO VALOR FISIOLOGICO: CARACTERIZACION IN VITRO, IN SITU E IN VIVO DE SU MORFOLOGIA Y FENOTIPO

PID2021-122409OB-C22

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION PARA LA INVESTIGACION MEDICA APLICADA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Multimodal evaluation of drug antibacterial activity reveals cinnamaldehyde analog anti-biofilm effects against Haemophilus influenzae

  • Asensio-López, J.
  • Lázaro-Díez, María
  • Hernández-Cruz, T. M.
  • Blanco-Cabra, N.
  • Sorzabal-Bellido, I.
  • Arroyo-Urea, Eva María
  • Buetas, E.
  • González-Paredes, Ana
  • Ortiz de Solórzano, C.
  • Burgui, S.
  • Torrents, E.
  • Monteserín, M.
  • Garmendia, Juncal
Biofilm formation by the pathobiont Haemophilus influenzae is associated with human nasopharynx colonization, otitis media in children, and chronic respiratory infections in adults suffering from chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD). β-lactam and quinolone antibiotics are commonly used to treat these infections. However, considering the resistance of biofilm-resident bacteria to antibiotic-mediated killing, the use of antibiotics may be insufficient and require being replaced or complemented with novel strategies. Moreover, unlike the standard minimal inhibitory concentration assay used to assess antibacterial activity against planktonic cells, standardization of methods to evaluate anti-biofilm drug activity is limited. In this work, we detail a panel of protocols for systematic analysis of drug antimicrobial effect on bacterial biofilms, customized to evaluate drug effects against H. influenzae biofilms. Testing of two cinnamaldehyde analogs, (E)-trans-2-nonenal and (E)-3-decen-2-one, demonstrated their effectiveness in both H. influenzae inhibition of biofilm formation and eradication or preformed biofilms. Assay complementarity allowed quantifying the dynamics and extent of the inhibitory effects, also observed for ampicillin resistant clinical strains forming biofilms refractory to this antibiotic. Moreover, cinnamaldehyde analog encapsulation into poly(lactic-co-glycolic acid) (PLGA) polymeric nanoparticles allowed drug vehiculization while maintaining efficacy. Overall, we demonstrate the usefulness of cinnamaldehyde analogs against H. influenzae biofilms, present a test panel that can be easily adapted to a wide range of pathogens and drugs, and highlight the benefits of drug nanoencapsulation towards safe controlled release., We are grateful to Alex Mira (FISABIO Foundation, Valencia, Spain) for providing access to the xCELLigence RTCA instrument. Funding Agencies and grant numbers: PhD studentship from Regional Navarra Govern, Spain, reference 0011-1408-2020-000007. Margarita Salas grant from Ministerio de Universidades, Spain, funded by the EU-Next Generation EU. This work has been funded by grants from AEI MICIU RTI2018-096369-B-I00, PID2021-125801OB-I00, MICIU PDI2021- 122409OB-C22; from SEPAR 875/2019; from Gobierno de Navarra PC150-151-152 and PC136-137-138; Atracción de Talento (Modalidad 1) program from Comunidad de Madrid, Spain, 2019-T1/IND-12906; Nanomedicine CSIC Hub, Spain, PIE202180E048. CIBER is an initiative from Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Novel Functionalization of Polyethylene Terephthalate (PETE) Membranes for Enhancing Cellular Adhesion in Organ-on-a-Chip Devices

  • Sobejano de la Merced, Carlos
  • Doveri, Lavinia Rita
  • Cortés-Domínguez, Iván
  • Garmendia, Juncal
  • Díaz Fernández, Antonio
  • Ortiz-de-Solórzano, Carlos
Resumen del trabajo presentado en el EUROoCS Conference 2024, celebrado en Milán (Italia), del 2 al 5 de julio de 2025, Born to model the complexity of human physiology, organ-on-chip devices (OOC) remain promising preclinical models. Boosting their usage, the Food and Drug Administration (FDA) has recently adopted this technology as a complementary nonclinical testing option [1]. Despite this promising future, there are still some challenging issues that need to be addressed to improve the OOC¿s physiological relevance, the lack of reproducibility being probably the most important one. This is commonly due to the propagation of experimental errors during the fabrication and manipulation of the chips [2]. Specifically, one of the most challenging aspects of OOC devices is the appropriate cellularization of the surfaces. To this end, some authors propose adsorption of proteins to the surfaces of interest to increase interactions between these and the cellular entities [3]. However, these interactions are usually too weak to handle the shear stresses produced in the microfluidic channels by the flows, leading to uncontrolled cell detachment. This causes variability of the populations adhered on each chip, complicating the reproducibility of the results. Furthermore, the adhesion capacity of the cells to the surfaces limits the flows that can be produced, limiting the extent of their potential application. In summary, it is crucial to define robust, reliable surface coating protocols to improve cell adhesion to the chips¿ surfaces. The objective of this work is to present a robust protocol for surface treatment to enhance the adhesion of cellular components of an airway-on-chip. Specifically, we present a novel experimental setup for the functionalization of polyethylene terephthalate (PETE) porous membranes. PETE is widely used as an interface surface for multilayer OOC¿s [4]. The protocol proposed is inspired by alkaline treatments performed to PETE fibers in the textile industry [5] and by techniques used to functionalize polylactic acid nanoparticles [6]. The membranes first undergo controlled hydrolyzation with sodium hydroxide that leads to the increment of exposed carboxylic groups in the surface, followed by their activation by 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and N-hydroxysuccinimide (NHS), and ended with the coating of different proteins (collagen I, polylysine, etc.). Thanks to this protocol, covalent bonding can be produced between the proteins and the surface. For characterizing the resulting surfaces and ensuring the integrity of the membranes, we have performed several surface analysis techniques such as scanning electron microscopy (SEM), UV-Vis spectroscopy and traction assays, demonstrating that the base characteristics of the substrate have not been altered (i.e., pore size or opacity). Furthermore, we have determined the chemical properties of membranes treated with different protein solutions by analyzing their Z potential and the dispersive and polar components of their surface tension, observing a difference between the control samples and the modified ones. Finally, the functionalization of the membranes has been tested using pulmonary epithelial and vascular cell types under both static and dynamic conditions, using micropatterned channels [7], observing differences in cell adhesion, as well as in cell resistance to different flows. The findings along this work will generate a new set of surface treatments of PETE that not only will lead to the development of more versatile devices in the OOC industry, but also more reproducible and robust ones., We are grateful to the Lab of Inorganic Nanochemistry (University of Pavia) for allowing C.S.M. to carry out a research stay, funded by a PhD grant from Ministerio de Ciencia e Innovación (MCIN), Spain, reference EST23/00718. We also thank Serena Schiavi and Giorgia Dal Pan from University of Pavia for their support. C.S.M. is funded by a PhD grant from MCIN, Spain, reference FPU20/06252. This work has been funded by grants from MCIN, Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033/) and FEDER Una manera de hacer Europa, PDI2021-122409OB-C22 (C.O.S., I.C.D.); and Gobierno de Navarra, PC137 (C.O.S.).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Automatic segmentation and quantification of Nigrosome-1 neuromelanin and iron in MRI: A candidate biomarker for parkinson's disease

  • Ariz Galilea, Mikel
  • Martínez, Martín
  • Álvarez, Ignacio
  • Fernández Seara, María Asunción
  • Castellanos, Gabriel
  • Catalonian Neuroimaging Parkinson's Disease Consortium
  • Pastor, Pau
  • Pastor, María A.
  • Ortiz de Solórzano, Carlos
Background: There is a lack of automated tools for the segmentation and quantification of neuromelanin (NM) and iron in the nigrosome-1 (N1). Existing tools evaluate the N1 sign, i.e., the presence or absence of the ‘swallow-tail’ in iron-sensitive MRI, or globally analyze the MRI signal in an area containing the N1, without providing a volumetric delineation. Purpose: Present an automated method to segment the N1 and quantify differences in N1's NM and iron content between Parkinson's disease (PD) patients and healthy controls (HCs). Study whether N1 degeneration is clinically related to PD and could be used as a biomarker of the disease. Study Type: Prospective. Subjects: Seventy-one PD (65.3 ± 10.3 years old, 34 female/37 male); 30 HC (62.7 ± 7.8 years old, 17 female/13 male). Field Strength/Sequence: 3 T Anatomical T1-weighted MPRAGE, NM-MRI T1-weighted gradient with magnetization transfer, susceptibility-weighted imaging (SWI). Assessment: N1 was automatically segmented in SWI images using a multi-image atlas, populated with healthy N1 structures manually annotated by a neurologist. Relative NM and iron content were quantified and their diagnostic performance assessed and compared with the substantia nigra pars compacta (SNc). The association between image parameters and clinically relevant variables was studied. Statistical Tests: Nonparametric tests were used (Mann-Whitney's U, chi-square, and Friedman tests) at P = 0.05. Results: N1's relative NM content decreased and relative iron content increased in PD patients compared with HCs (NM-CRHC = 22.55 ± 1.49; NM-CRPD = 19.79 ± 1.92; NM-nVolHC = 2.69 × 10-5 ± 1.02 × 10-5; NM-nVolPD = 1.18 × 10-5 ± 0.96 × 10−5; Iron-CRHC = 10.51 ± 2.64; Iron-CRPD = 19.35 ± 7.88; Iron-nVolHC = 0.72 × 10-5 ± 0.81 × 10-5; Iron-nVolPD = 2.82 × 10−5 ± 2.04 × 10−5). Binary logistic regression analyses combining N1 and SNc image parameters yielded a top AUC = 0.955. Significant correlation was found between most N1 parameters and both disease duration (ρNM-CR = -0.31; ρiron-CR = 0.43; ρiron-nVol = 0.46) and the motor status ρNM-nVol = -0.27; ρiron-CR = 0.33; ρiron-nVol = 0.28), suggesting NM reduction along with iron accumulation in N1 as the disease progresses. Data Conclusion: This method provides a fully automatic N1 segmentation, and the analyses performed reveal that N1 relative NM and iron quantification improves diagnostic performance and suggest a relative NM reduction along with a relative iron accumulation in N1 as the disease progresses. Evidence Level: 1. Technical Efficacy: Stage 1., The authors would like to thank all the subjects who participated in this study. This work was supported by Instituto de Salud Carlos III (ISCIII) and European Union NextGenerationEU/PRTR (grant number PMP22/00100) and by FEDER and the Spanish Ministry of Science and Innovation and Universities MCIN/AEI (10.13039/501100011033) (grant numbers PDI2021-122409OB-C22, RTI2018-094494-B-C22, and TED2021-131300B-I00 [C.O.S] and SAF2016-81016-R [M.A.P]). The funders had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data and the final responsibility to submit for publication.